• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者的临床评估步行能力与实际步行表现对比

Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis.

作者信息

Mate Kedar K V, Mayo Nancy E

出版信息

Int J MS Care. 2020 May-Jun;22(3):143-150. doi: 10.7224/1537-2073.2019-047. Epub 2020 Jun 15.

DOI:10.7224/1537-2073.2019-047
PMID:32607077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7307876/
Abstract

BACKGROUND

Ecological validity is an important psychometric property when assessing function. How a person with multiple sclerosis (MS) performs in clinical settings and in natural environments can be quite different. Walking is the most frequently assessed and recommended way to maintain health in a progressive disease such as MS. The objective was to estimate the extent to which clinical tests of walking capacity differ from real-world walking performance in people with MS.

METHODS

Ninety-eight women and 27 men with MS were assessed using the 6-Minute Walk Test (6MWT) and wore an accelerometer for 7 consecutive days. Mean number of steps, mean number of steps at a brisk cadence or faster, and cumulative time per week spent walking at a brisk cadence or faster were regressed on 6MWT categories using quantile (median) regression. Contiguous steps were grouped into bouts of less than 5 minutes and 5 minutes or longer, and number of bouts 5 minutes or longer was regressed on 6MWT categories using a zero-inflated Poisson model.

RESULTS

A total of 869 patient-days of accelerometer data were available. Mean total number of steps per day was greater for people with higher walking capacity (6MWT distance, ≥600 m). However, this group spent a small proportion of time walking at higher cadence bands. Compared with people with 6MWT distance of at least 600 m, people walking less than 500 m had approximately half the rate of walking bouts of 5 minutes or longer. Positive mood and fewer exercise barriers predicted more walking bouts of at least 5 minutes.

CONCLUSIONS

Study participants with MS spent a small proportion of time walking at a health-promoting intensity.

摘要

背景

生态效度是评估功能时一项重要的心理测量属性。患有多发性硬化症(MS)的人在临床环境和自然环境中的表现可能有很大差异。步行是在诸如MS这种进行性疾病中最常被评估和推荐的保持健康的方式。目的是估计MS患者步行能力的临床测试与现实世界中步行表现的差异程度。

方法

对98名患有MS的女性和27名患有MS的男性进行6分钟步行测试(6MWT)评估,并连续7天佩戴加速度计。使用分位数(中位数)回归,将平均步数、轻快节奏或更快节奏下的平均步数以及每周在轻快节奏或更快节奏下步行所花费的累计时间与6MWT类别进行回归分析。连续的步数被分组为少于5分钟和5分钟或更长时间的步行时段,使用零膨胀泊松模型将5分钟或更长时间的步行时段数量与6MWT类别进行回归分析。

结果

总共获得了869个患者日的加速度计数据。步行能力较高(6MWT距离≥600米)的人每天的平均总步数更多。然而,该组在较高节奏频段步行的时间占比很小。与6MWT距离至少为600米的人相比,步行距离小于500米的人5分钟或更长时间的步行时段发生率约为其一半。积极情绪和较少的运动障碍预示着至少5分钟的步行时段更多。

结论

患有MS的研究参与者在以促进健康的强度步行上花费的时间占比很小。

相似文献

1
Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis.多发性硬化症患者的临床评估步行能力与实际步行表现对比
Int J MS Care. 2020 May-Jun;22(3):143-150. doi: 10.7224/1537-2073.2019-047. Epub 2020 Jun 15.
2
Free-Living Peak Cadence in Multiple Sclerosis: A New Measure of Real-World Walking?多发性硬化症中的自由生活峰值步频:现实行走的新测量指标?
Neurorehabil Neural Repair. 2023 Oct;37(10):716-726. doi: 10.1177/15459683231206741. Epub 2023 Oct 21.
3
The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity.多发性硬化症患者的 2 分钟步行测试:步频与自由行走的相关性不支持生态效度。
Int J Environ Res Public Health. 2020 Dec 4;17(23):9044. doi: 10.3390/ijerph17239044.
4
Assessment of Free-Living Cadence Using ActiGraph Accelerometers Between Individuals With and Without Anterior Cruciate Ligament Reconstruction.使用 ActiGraph 加速度计评估 ACL 重建前后个体的自由生活节奏。
J Athl Train. 2020 Sep 1;55(9):994-1000. doi: 10.4085/1062-6050-425-19.
5
Real-world walking cadence in people with COPD.慢性阻塞性肺疾病患者的实际步行节奏。
ERJ Open Res. 2024 Mar 4;10(2). doi: 10.1183/23120541.00673-2023. eCollection 2024 Mar.
6
Using cadence to study free-living ambulatory behaviour.利用节奏研究自由活动的行为。
Sports Med. 2012 May 1;42(5):381-98. doi: 10.2165/11599170-000000000-00000.
7
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.康复后多发性硬化症患者行走能力测试的生态有效性。
PLoS One. 2019 Aug 1;14(8):e0220613. doi: 10.1371/journal.pone.0220613. eCollection 2019.
8
Ecological validity of walking capacity tests in multiple sclerosis.多发性硬化症步行能力测试的生态效度
PLoS One. 2015 Apr 16;10(4):e0123822. doi: 10.1371/journal.pone.0123822. eCollection 2015.
9
Prediction of 6-minute walk performance in patients with peripheral artery disease.外周动脉疾病患者6分钟步行表现的预测
J Vasc Surg. 2017 Oct;66(4):1202-1209. doi: 10.1016/j.jvs.2017.03.438. Epub 2017 Jun 21.
10
Short inertial sensor-based gait tests reflect perceived state fatigue in multiple sclerosis.基于短惯性传感器的步态测试反映多发性硬化症中的感知状态疲劳。
Mult Scler Relat Disord. 2022 Feb;58:103519. doi: 10.1016/j.msard.2022.103519. Epub 2022 Jan 14.

引用本文的文献

1
Comparability of Methods for Remotely Assessing Gait Quality.远程评估步态质量方法的可比性
Sensors (Basel). 2025 Jun 14;25(12):3733. doi: 10.3390/s25123733.
2
Step-Count Distribution as an Indicator of Walking Reserve in People with Gait Vulnerabilities.步数分布作为步态易损人群步行储备指标
Can Geriatr J. 2025 Jun 4;28(2):115-124. doi: 10.5770/cgj.28.763. eCollection 2025 Jun.
3
Walking performance differs between people with multiple sclerosis who perform distinct types of exercise.进行不同类型锻炼的多发性硬化症患者的行走能力存在差异。
Neurodegener Dis Manag. 2024;14(3-4):75-85. doi: 10.1080/17582024.2024.2389037. Epub 2024 Aug 19.
4
Measurement Properties of Backward Walking and Its Sensitivity and Feasibility in Predicting Falls in People With Multiple Sclerosis.向后行走的测量属性及其在预测多发性硬化症患者跌倒方面的敏感性和可行性。
Int J MS Care. 2024 Jun 24;26(Q3):155-166. doi: 10.7224/1537-2073.2023-091. eCollection 2024 May.
5
Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context.在肿瘤学背景下2分钟步行试验和10米步行试验的可行性、标准效度和结构效度。
Heliyon. 2023 Nov 10;9(11):e22180. doi: 10.1016/j.heliyon.2023.e22180. eCollection 2023 Nov.
6
An observational study to assess validity and reliability of smartphone sensor-based gait and balance assessments in multiple sclerosis: Floodlight GaitLab protocol.一项评估基于智能手机传感器的步态和平衡评估在多发性硬化症中的有效性和可靠性的观察性研究:泛光灯步态实验室方案。
Digit Health. 2023 Oct 19;9:20552076231205284. doi: 10.1177/20552076231205284. eCollection 2023 Jan-Dec.
7
Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective.可穿戴传感器技术评估多发性硬化症患者的运动功能:系统综述和展望。
J Med Internet Res. 2023 Jul 27;25:e44428. doi: 10.2196/44428.
8
Agreement, Reliability, and Concurrent Validity of an Outdoor, Wearable-Based Walk Ratio Assessment in Healthy Adults and Chronic Stroke Survivors.健康成年人和慢性中风幸存者户外可穿戴式步行比率评估的一致性、可靠性和同时效度。
Front Physiol. 2022 Jun 20;13:857963. doi: 10.3389/fphys.2022.857963. eCollection 2022.
9
Making Every Step Count: Minute-by-Minute Characterization of Step Counts Augments Remote Activity Monitoring in People With Multiple Sclerosis.让每一步都有价值:按分钟对步数进行特征分析可增强对多发性硬化症患者的远程活动监测。
Front Neurol. 2022 May 23;13:860008. doi: 10.3389/fneur.2022.860008. eCollection 2022.

本文引用的文献

1
What interventions are used to improve exercise adherence in older people and what behavioural techniques are they based on? A systematic review.有哪些干预措施可用于提高老年人的锻炼依从性,以及它们基于哪些行为技术?系统评价。
BMJ Open. 2017 Dec 14;7(12):e019221. doi: 10.1136/bmjopen-2017-019221.
2
New Insights into Multiple Sclerosis Clinical Course from the Topographical Model and Functional Reserve.从地形模型和功能储备看多发性硬化临床病程的新见解
Neurol Clin. 2018 Feb;36(1):13-25. doi: 10.1016/j.ncl.2017.08.003. Epub 2017 Oct 18.
3
Real-world walking in multiple sclerosis: Separating capacity from behavior.多发性硬化症患者的真实行走情况:区分能力与行为。
Gait Posture. 2018 Jan;59:211-216. doi: 10.1016/j.gaitpost.2017.10.015. Epub 2017 Oct 16.
4
Gait Speed Assessment in Transcatheter Aortic Valve Replacement: A Step in the Right Direction.经导管主动脉瓣置换术中的步态速度评估:朝着正确方向迈出的一步。
Circ Cardiovasc Interv. 2017 Sep;10(9). doi: 10.1161/CIRCINTERVENTIONS.117.005746.
5
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.MSOAC 方法制定用于衡量和监测多发性硬化症残疾的表现结果。
Mult Scler. 2018 Oct;24(11):1469-1484. doi: 10.1177/1352458517723718. Epub 2017 Aug 11.
6
Residents of highly walkable neighbourhoods in Canadian urban areas do substantially more physical activity: a cross-sectional analysis.加拿大城市地区高度适宜步行社区的居民进行的体育活动显著更多:一项横断面分析。
CMAJ Open. 2016 Dec 1;4(4):E720-E728. doi: 10.9778/cmajo.20160068. eCollection 2016 Oct-Dec.
7
Ecological validity of walking capacity tests in multiple sclerosis.多发性硬化症步行能力测试的生态效度
PLoS One. 2015 Apr 16;10(4):e0123822. doi: 10.1371/journal.pone.0123822. eCollection 2015.
8
Clinical importance of steps taken per day among persons with multiple sclerosis.多发性硬化症患者每天采取的步骤的临床重要性。
PLoS One. 2013 Sep 4;8(9):e73247. doi: 10.1371/journal.pone.0073247. eCollection 2013.
9
The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial.锻炼在改变多发性硬化症患者结局中的作用:一项随机试验。
BMC Neurol. 2013 Jun 28;13:69. doi: 10.1186/1471-2377-13-69.
10
Exercise barriers and preferences among women and men with multiple sclerosis.多发性硬化症患者中男女的运动障碍和偏好。
Disabil Rehabil. 2013 Mar;35(5):353-61. doi: 10.3109/09638288.2012.742574.